Quest Laboratories Limited
ListedSMEHealthcare / Pharmaceuticals · NSE
Founded in June 1998, Quest Laboratories Limited is a well-known pharmaceutical company that produces a wide range of medicines, including antibiotics, antimalarials, pain relievers, respiratory treatments, diabetes medications, and antidepressants. The company operates across 12 states and 2 union territories in India, including Uttar Pradesh, Maharashtra, Delhi, Karnataka, and more. Headquartered in Dhar, Madhya Pradesh, Quest Laboratories runs advanced manufacturing facilities that meet strict international quality standards like WHO GMP, GLP, and ISO certifications. With a skilled team of 83 professionals handling production, quality control, engineering, inventory, and administration, the company is dedicated to maintaining top-quality standards and delivering reliable medical solutions.
Price Band
₹93 – ₹97
Issue Size
₹43.16 Cr
Lot Size
1200 shares
GMP
₹80
+82.5%
Est. Listing
₹177
at current GMP
Subscribed
85.34x
overall
Open
15 May 2024
Close
17 May 2024
Allotment
21 May 2024
Refund
22 May 2024
Demat Credit
23 May 2024
Listing
23 May 2024
Last updated 12 days ago
Overall Subscription
85.34x
Total Demand
QIB Multiplier
57.20x
Institutions & Funds
NII / HNI
184.45x
High Net-Worth
Retail (RII)
57.63x
Individual Bidders
Category-Wise Subscription Breakup
Live bidding breakdown by institutional, non-institutional, and retail investors
| Category | Shares Offered | Shares Applied / Bid | Times Subscribed |
|---|---|---|---|
| QIB | 831,600 | 47,571,600 | 57.20x |
| NIB | 655,200 | 120,852,000 | 184.45x |
| RETAIL | 1,498,800 | 86,370,000 | 57.63x |
| Total | 2,985,600 | 254,793,600 | 85.34x |
Application-Wise Breakup
Total unique applications received across retail and HNI tranches
| Category | Applications Reserved | Applications Received | Times Subscribed |
|---|---|---|---|
| Retail (RII) | 1,298 | 74,804 | 57.63x |
| HNIs (10L +) | 8 | 1,476 | 184.45x |
| HNIs (2-10L) | 40 | 7,378 | 184.45x |
| Total Applications | 1,346 | 83,658 | 62.15x |
Day-Wise Subscription Progress
Track continuous institutional and retail bidding order books for all active issues on the ipo live subscription feed.
About Quest Laboratories Limited Public Issue & Market Profile
Quest Laboratories Limited is bringing an initial public offering (IPO) in the Healthcare / Pharmaceuticals sector with an aggregate issue size of ₹43.16 Crores. The shares are offered at a price band of ₹93 to ₹97 per equity share on NSE. Currently, market analysts recommend evaluating the company's financial valuation, price-to-earnings (P/E) multiple, and peer comparison prior to submitting bids.
Bidding & Quota Instructions:
The public offer consists of a fresh issue and offer-for-sale structured under SEBI regulations. Bidding is open to Qualified Institutional Buyers (QIB), Non-Institutional Bidders (NII/HNI), and Retail Individual Investors (RII). Applications can be submitted online using ASBA or UPI mandate through certified stock brokers and net banking portals.
Allotment Reconciliation Schedule:
Following the close of bidding on 2024-05-17, the basis of allotment is scheduled to be finalized on 2024-05-21. Investors can verify their application status online by submitting their PAN card number, Application Number, or DP Client ID on the registrar's official portal (Bigshare Services Private Limited) or the BSE allotment checking window.
Frequently Asked Questions
What is Quest Laboratories Limited IPO GMP today?
The latest Grey Market Premium (GMP) for Quest Laboratories Limited IPO is ₹80 per equity share. Based on the upper price band of ₹93 to ₹97 per equity share, the estimated listing price is ₹177 (+82.5% expected listing gain).
What is the expected profit per lot for Quest Laboratories Limited IPO?
With a lot size of 1200 shares and current GMP of ₹80, the expected profit per application lot is approx ₹96,000 (+82.5% gain). Minimum application cost is approx ₹1,16,400.
What is the issue size and price band for Quest Laboratories Limited IPO?
The Quest Laboratories Limited IPO aggregate issue size is ₹43.16 Crores with an equity price band set at ₹93 to ₹97 per equity share. The retail lot size is 1200 shares requiring a minimum capital outlay of approx. ₹1,16,400.
How can I check Quest Laboratories Limited IPO live subscription demand?
Live subscription figures are compiled real-time from the NSE and BSE bidding engines. Currently, overall subscription is 85.34x (Retail: 57.63x, QIB: 57.20x, NII: 184.45x). You can track live multiples directly on our dedicated subscription page.
Where and when will Quest Laboratories Limited IPO allotment status be published?
The basis of allotment will be published on the official registrar portal (Bigshare Services Private Limited) and the BSE status verification website on or around 2024-05-21. Investors can verify status using PAN card or application number.
When is the listing date for Quest Laboratories Limited IPO?
Quest Laboratories Limited shares are scheduled to list on NSE on 2024-05-23.